# Therapeutic Drug Monitoring in Patients With Difficult-to-Treat Gram-Negative Bacterial Infections

> **NCT05942157** · NA · UNKNOWN · sponsor: **Singapore General Hospital** · enrollment: 810 (estimated)

## Conditions studied

- Sepsis
- Hemodynamic Instability
- Bacterial Infections
- Therapeutic Drug Monitoring
- Antimicrobial Resistance

## Interventions

- **OTHER:** Therapeutic Drug Monitoring (TDM)

## Key facts

- **NCT ID:** NCT05942157
- **Lead sponsor:** Singapore General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-29
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 810 (ESTIMATED)
- **Last updated:** 2023-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05942157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05942157, "Therapeutic Drug Monitoring in Patients With Difficult-to-Treat Gram-Negative Bacterial Infections". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05942157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*